Treating COVID-19 in patients with diabetes
March 17, 2020
Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.
Dapagliflozin approved for reducing HF hospitalization in diabetes
October 21, 2019
It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.